Results 111 to 120 of about 20,944 (184)

Synthetic peptide analogs derived from bcr/abl fusion proteins and the induction of heteroclitic human T-cell responses.

Haematologica, 2006
Chronic myelogenous leukemia (CML) presents a unique opportunity to develop therapeutic strategies using vaccination against a truly tumor-specific antigen that is also the oncogenic protein required for neoplasia. We have shown in phase I and II trials that a tumor-specific, bcr-abl-derived peptide vaccine can be safely administered to patients with ...
Javier, Pinilla-Ibarz, Tatyana, Korontsvit, Victoriya, Zakhaleva, Wendy, Roberts, David A, Scheinberg   +4 more
openaire   +1 more source

Flow cytometric detection of BCR-ABL fusion proteins in leukemia patients via an immunobead assay

, 2011
Peer ...
Weerkamp, F., Flores-Montero, Juan, Orfao, Alberto   +2 more
openaire   +1 more source

Identification of a <i>Musashi2</i> translocation as a novel oncogene in myeloid leukemia. [PDF]

Elife
Spinler K, Hamilton M, Bajaj J, Shima Y, Diaz E, Kritzik M, Reya T.   +6 more
europepmc   +1 more source

Exosome and BCR-ABL mediated molecular alterations in endothelial cells in chronic myeloid leukemia: identification of seven genes and their regulatory network. [PDF]

PeerJ
Shen Z, Cao H, Zhou Y, Mao W, Liu K, Zhu J, He M, Mao Y, Luo N, Feng L, Le H, Song L, Li H, Yousafzai YM, Zia A, Gu X, Zhang S.   +16 more
europepmc   +1 more source

The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype [editorial; comment] [PDF]

Blood, 1996
openaire   +1 more source

Olverembatinib for 8p11 myeloproliferative syndrome with a positive BCR-FGFR1 fusion gene: a case report. [PDF]

Ann Hematol
Wu M, Huang L, Yao Y, Xu Y, Yang Y, Luo J, Liu Z.   +6 more
europepmc   +1 more source

A case report of mixed-phenotype acute leukemia with atypical BCR::ABL1 e13a3 fusion gene. [PDF]

Medicine (Baltimore)
Zhou Y, Liu M, Zhao Y, Zhang R, Guo Q, Wang Z, Nie Y, Yang J, Shi M.   +8 more
europepmc   +1 more source

Molecular genetic characteristics and clinical significance of childhood acute lymphoblastic leukemia. [PDF]

Front Pediatr
Zhu Z, Yan J.
europepmc   +1 more source

Autophosphorylation of oncoprotein TEL-ABL in myeloid and lymphoid cells confers resistance to the allosteric ABL inhibitor asciminib. [PDF]

Sci Signal
Muratcioglu S, Eide CA, Hung CL, Gorday K, Sumpena E, Zuo W, Groves JT, Druker BJ, Kuriyan J.   +8 more
europepmc   +1 more source

Natural Products Targeting BCR-ABL: A Plant-Based Approach to Chronic Myeloid Leukemia Treatment. [PDF]

Molecules
Pechlivani L, Giannakis A, Sioka C, Alexiou GA, Kyritsis AP.   +4 more
europepmc   +1 more source